Back to Search
ANN RINEHART, MD
MD
Nephrology Physician
NPI: 1922063338IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
32912(MN)
Education
PENNSYLVANIA STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1987
Research & Publications (14)
Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals.
PMID 19168389·J Clin Virol·2009
8-other
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients.
PMID 19114860·AIDS·2009
4-observational
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data.
PMID 18360290·J Acquir Immune Defic Syndr·2008
8-other
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.
PMID 17041858·J Infect Dis·2006
4-observational
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).
PMID 15937768·Clin Infect Dis·2005
4-observational
TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial.
PMID 15905675·AIDS·2005
3-trial
A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.
PMID 15793365·J Acquir Immune Defic Syndr·2005
3-trial
Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial.
PMID 14986258·Clin Infect Dis·2004
3-trial
A randomized, double-blind, placebo-controlled trial of TMC125 as 7-day monotherapy in antiretroviral naive, HIV-1 infected subjects.
PMID 14600520·AIDS·2003
3-trial
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.
PMID 12626886·J Acquir Immune Defic Syndr·2003
3-trial
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
PMID 12599088·J Infect Dis·2003
3-trial
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.
PMID 11873001·AIDS·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 PHALEN BLVD, MAIL STOP 41103C
ST PAUL, MN 55101 - Phone
- (651) 254-7850
Quick Facts
- NPI
- 1922063338
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 14
Are you this provider?
Claim Your Profile